AC-46261 - lisinopril-dihydrate | 83915-83-7
Lamentamos, não foi encontrado nenhum produto com a referência AC-46261, mas por favor, verifique os seguintes produtos semelhantes:
Lisinopril Dihydrate
CAS:Fórmula:C21H31O5N3·2H2OPureza:>98.0%(T)Cor e Forma:White to Almost white powder to crystalPeso molecular:441.53Lisinopril dihydrate
CAS:Lisinopril dihydrateFórmula:C21H31N3O5Pureza:91.5%Cor e Forma:WhitePeso molecular:405.22637Lisinopril dihydrate
CAS:Lisinopril dihydrate （MK-521) is an orally bioavailable, long-acting angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.Fórmula:C21H35N3O7Pureza:98.83% - 99.22%Cor e Forma:White To Off-White Crystalline PowderPeso molecular:441.52Lisinopril dihydrate
CAS:Produto ControladoFórmula:C21H31N3O5H2OCor e Forma:NeatPeso molecular:441.52Lisinopril Dihydrate
CAS:Produto ControladoFórmula:C21H31N3O5H2OCor e Forma:NeatPeso molecular:441.52LISINOPRIL DIHYDRATE CRS
CAS:LISINOPRIL DIHYDRATE CRSFórmula:C21H35N3O7Cor e Forma:PowderPeso molecular:441.5185Lisinopril dihydrate, 10mM (in H2O)
CAS:Lisinopril dihydrate, 10mM (in H2O)Pureza:≥98%Peso molecular:441.52g/mol(S)-Lisinopril Dihydrate
CAS:<p>Stability Hygroscopic<br>Applications An orally active angiotensin-converting enzyme (ACE) inhibitor. S,S,S-Isomer of Lisinopril.<br>References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Fórmula:C21H31N3O5·2H2OCor e Forma:WhitePeso molecular:441.52LISINOPRIL FOR SYSTEM SUITABILITY A CRS
CAS:LISINOPRIL FOR SYSTEM SUITABILITY A CRSCor e Forma:PowderLisinopril
CAS:Cardiovascular drugs, not elsewhere specified or includFórmula:C21H31N3O5·2H2OCor e Forma:White Off-White PowderPeso molecular:405.226372-Deoxy-3,4,6-tri-O-pivaloyl-D-glucopyranosyl azide
CAS:2-Deoxy-3,4,6-tri-O-pivaloyl-D-glucopyranosyl azide is a drug that regulates the blood pressure. It is an oral hypoglycaemic agent that has been shown to lower blood sugar levels in patients with type 2 diabetes mellitus. The drug is metabolized in the liver by cytochrome p450 enzymes and can cause interactions with drugs such as lisinopril, which are metabolized by these enzymes. 2DGPA has been shown to be effective at lowering blood pressure in a low-dose group of patients with essential hypertension. The signal peptide sequence was detected in the protein sequencing of a biological sample from rats treated with 2DGPA. This drug also reduces natriuretic peptide levels and has a rate constant of 4s−1M−1s−1.Fórmula:C21H35N3O7Pureza:Min. 95%Peso molecular:441.53 g/molL-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)
CAS:Fórmula:C21H35N3O7Pureza:99%Cor e Forma:SolidPeso molecular:441.5185Lisinopril
CAS:Fórmula:C21H31O5N3·2H2OPureza:(Titration) 98.0 - 102.0 % (anhydrous basis)Cor e Forma:White to almost white crystalline powderPeso molecular:441.52
![L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003RAL.webp&w=3840&q=75)
